Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric...

31
Last updated: 1/17/2020 Page 1 of 31 Kevin W. Chamberlin, PharmD, FASCP Primary Business Address: University of Connecticut School of Pharmacy 69 North Eagleville Road, U-3092 Storrs, CT 06269-3092 Office: 860.679.2281 E-mail: Professional Licensure: [email protected] Connecticut License No.: 9922 Immunization CPN No.: 202-0007 Naloxone 10/1/2015 Academic Degrees and Post-Graduate Training 2003 – 2004 ASHP-Accredited Specialized Residency in Geriatric Pharmacy Practice VA Connecticut Healthcare System and University of Connecticut School of Pharmacy West Haven, CT 1997 – 2003 Doctor of Pharmacy University of Connecticut School of Pharmacy Storrs, CT 1997 – 2001 Bachelor of Science, Pharmacy Studies University of Connecticut School of Pharmacy Storrs, CT Certificate & Workshop Training 2019 – present Connecticut Comprehensive Pain Center UConn Health Farmington, CT 2019 – 2020 American Association of Colleges of Pharmacy – Academic Leadership Fellows Program (AACP-ALFP), Cohort 16 Alexandria, VA 2016 ASHP Residency Program Design and Conduct Workshop for PGY1 Existing Programs National Pharmacy Preceptors Conference Washington, DC 2015 Naloxone Training Certification – State of Connecticut Public Act 15-198 Section 6(b) University of Connecticut School of Pharmacy

Transcript of Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric...

Page 1: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 1 of 31

Kevin W. Chamberlin, PharmD, FASCP

Primary Business Address:

University of Connecticut School of Pharmacy 69 North Eagleville Road, U-3092

Storrs, CT 06269-3092

Office: 860.679.2281

E-mail: Professional Licensure: [email protected] Connecticut License No.: 9922

Immunization CPN No.: 202-0007 Naloxone 10/1/2015

Academic Degrees and Post-Graduate Training 2003 – 2004 ASHP-Accredited Specialized Residency in Geriatric Pharmacy Practice

VA Connecticut Healthcare System and University of Connecticut School of Pharmacy West Haven, CT

1997 – 2003 Doctor of Pharmacy

University of Connecticut School of Pharmacy Storrs, CT

1997 – 2001 Bachelor of Science, Pharmacy Studies

University of Connecticut School of Pharmacy Storrs, CT

Certificate & Workshop Training 2019 – present Connecticut Comprehensive Pain Center

UConn Health Farmington, CT

2019 – 2020 American Association of Colleges of Pharmacy – Academic Leadership

Fellows Program (AACP-ALFP), Cohort 16 Alexandria, VA

2016 ASHP Residency Program Design and Conduct Workshop for PGY1

Existing Programs National Pharmacy Preceptors Conference Washington, DC

2015 Naloxone Training Certification – State of Connecticut Public Act 15-198

Section 6(b) University of Connecticut School of Pharmacy

Page 2: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 2 of 31

2013 Teaching and Learning Certificate University of Connecticut School of Pharmacy Storrs, CT

2011 ASHP Residency Learning System Workshop – PGY1 New Residency

Programs New Orleans, LA

2007 ASHP Pain Management and Palliative Care Workshop 2007

Las Vegas, NV 2005 APhA Certified Immunization Specialist & Trainer

APhA Pharmacy Based Immunization Delivery Certificate Program for Pharmacists

2003 ASHP Residency Learning System Workshop – Specialized Residency

Programs New Orleans, LA

Professional Experience Aug 2019 – present Interim Associate Dean for Admissions and

Student Affairs University of Connecticut School of Pharmacy

Storrs, CT

2014 – present Associate Clinical Professor of Pharmacy

Practice [Areas of specialty: Internal Medicine, Geriatrics, Pain Management] University of Connecticut School of Pharmacy

Storrs, CT &

Farmington, CT

2012 – present Assistant Department Head

University of Connecticut School of Pharmacy Department of Pharmacy Practice

Storrs, CT

2012 – present PGY1 Pharmacy Residency Program Director

John Dempsey Hospital /UConn Health Center Farmington, CT

2011 – 2014 Assistant Clinical Professor of Pharmacy

Practice [Areas of specialty: Internal Medicine, Geriatrics, Pain Management] University of Connecticut School of Pharmacy

Storrs, CT &

Farmington, CT

2009 – 2011 Manager, Long-term care Division

(appt’d 10/2010) and Staff Pharmacist Beacon Prescriptions

New Britain, CT

2008 – 2011 Long-Term Care Consultant and Staff

Pharmacist RxHealth

Hartford, CT

Page 3: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 3 of 31

2004 – 2009 Assistant Clinical Professor of Pharmacy

Practice [Areas of specialty: Internal Medicine, Geriatrics, Pain Management] University of Connecticut School of Pharmacy

Storrs, CT &

Farmington, CT

2003 – 2004 Adjunct Assistant Clinical Professor

University of Connecticut School of Pharmacy Storrs, CT

2003 – 2009 Staff Pharmacist, per diem

CVS/pharmacy CT

Jun 2000 – Aug 2000

Junior Commissioned Officer Student Training (JrCOSTEP) United States Public Health Service, Indian Health Services (USPHS-IHS)

Fort Washakie, WY

Teaching Experience 2012 – present PHRx 5103 & 5124: Internal Medicine APPE

University of Connecticut School of Pharmacy & John Dempsey Hospital /UConn Health

Farmington, CT

2014 – present Adjunct Associate Clinical Professor

University of Connecticut School of Medicine Farmington, CT

2011 – 2014 Adjunct Assistant Clinical Professor

University of Connecticut School of Medicine Farmington, CT

2011 – present Core Faculty

University of Connecticut Center on Aging Farmington, CT

2011 – 2012 PHRx 5109: Geriatrics Ambulatory Care APPE

University of Connecticut School of Pharmacy & Geriatrics Associates, UConn Health Center

Farmington, CT

2008 – 2009 Adjunct Assistant Clinical Professor

University of Connecticut School of Medicine Farmington, CT

2007 – 2009 Core Faculty

University of Connecticut Center on Aging Farmington, CT

2006 – 2009 PHRM 286: General Medicine II Clerkship

University of Connecticut School of Pharmacy & John Dempsey Hospital /University of Connecticut Health Center

Farmington, CT

Page 4: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 4 of 31

2004 – 2009 PHRM 265: General Medicine I Clerkship University of Connecticut School of Pharmacy & John Dempsey Hospital /University of Connecticut Health Center

Farmington, CT

2004 – 2009 Assistant Clinical Professor of Pharmacy Practice

[Areas of specialty: Internal Medicine, Geriatrics, Pain Management] University of Connecticut School of Pharmacy

Storrs, CT

Jul 2003 – Jun 2004 Adjunct Assistant Clinical Professor

University of Connecticut Storrs, CT

Research & Grant Activities Funded Research Aug 2019 – Jan 2020

Andrews R, Chamberlin KW, Ozimek J, Rao S. “Connecticut Comprehensive Pain Center” Connecticut Office of Health Strategy (OHS). (15% FTE offset, 8/30 – 12/28/2019; 20% FTE offset, 12/29/19 – 1/31/2020).

2017 – 2019 Andrews R, Katz M, Agresta T, Hilario H, Labunko B, Lafreniere D, Preston

R, Simon R. “UConn Practice Transformation Network (PTN) Quality Improvement Initiatives for Pain. - $1.5 million (10% FTE offset, 3/2019 – 12/2019) Southern New England Practice Transformation Network (SNE-PTN) is funded through Centers for Medicare and Medicaid Services to be part of its Transforming Clinical Practices Initiative (TCPI). Subsequently, the SNE-PTN funds the UConn Health Comprehensive Center for Pain that began its pilot in March 2019.

Jan 7, 2013 – Jul 31, 2013

Rappaport S, Baker WB, Chamberlin KW. “Evaluation of a Pilot Pharmacy Service Across Transitions of Care to Reduce 30-day Postdischarge Healthcare Utilization Rates in Patients with Pneumonia or COPD Exacerbation.” - $3,620 American Society of Health-System Pharmacists Research and Education Foundation (ASHP Foundation) Pharmacy Resident Practice-Based Research Grant Program award.

Jan 2012 – Aug 2012

Holle L, Buckley T, Chamberlin KW, Fitzgerald J, Smith M, White CM. “2012 Guest Professorship Award: Daniel E. Buffington.” University of Connecticut – Office of the Vice President for Research – $10,700 Share his expertise on developing innovative, reimbursable, value-based pharmacy patient-care services, including MTM and CDTM, and his understanding of the landscape for obtaining reimbursement through legislation, business partnerships, and other innovative models, through a variety of formats, including lectures, seminars, informal discussions, and one-on-one and/or group consultations.

Feb 2005 Chamberlin KW, Jeffery SM. Rhode Island Geriatric Education Center

(RIGEC) Unrestricted Educational Grant – in support of geriatric health provider continuing education – $16,487

Page 5: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 5 of 31

Non-funded Research Jul 2019 – Jun 2020

Long A, Czerwinski J (PI), Rizal A, Kolodziej M, Emonds EE, Chamberlin KW. “Utilization of Pharmacy Student Trainees to Assist with Patient Discharge Education on Anticoagulation Therapy.” IRB #: exempt QA/QI. UConn Health.

Jul 2019 – Jun 2020

Bogdanska W, Holle L (PI), Chamberlin KW, Moran A, LeClair J. “Improving adherence to recommended laboratory monitoring and adherence assessment in patients receiving oral anticancer therapies.” IRB #: 20-008S-2. UConn Health.

Aug 2018 – Jun 2019

Holle L, LeClair J, Clement J, Chamberlin KW. “Documentation of Medical Marijuana Use in Cancer Patients.” IRB #: 18-2602. UConn Health.

Aug 2018 – Jun 2019

Salvo M, Emonds E, Chamberlin KW, Cavero S. “Impact of Pharmacy Resident Involvement in proton pump inhibitor (PPI) prescribing and deprescribing procedures in a primary care setting.” IRB #: 18-2630. UConn Health.

Jun 2018 – Jun 2019

Andrews R, Katz M, Barrack J, Chamberlin KW. “The Impact of Educational Interventions for Providers on Appropriate Monitoring of Patients on Long-term Opioid Pain Management.” QI determination Apr 5, 2018. UConn Health.

Aug 2017 – Aug 2018

Sahbani O, Kuszewski G (PI), Banach D, Chamberlin KW, Aeschlimann JR. “Financial and clinical impact of nasal methicillin resistant S. aureus (MRSA) polymerase chain reaction (PCR) swab in adult patients with pneumonia.” QA/QI project #: 976. UConn Health.

Jul 2017 – present

Mastrocola JB (PI), Perrin AE, Peterson DE, Chamberlin KW, Salvo M, Kim MJ, Clark-Dufner PC, Lazzarini Z, Mansilla-Rivera K, McCauley PS. “Impact of the new M Delta curriculum on health professional students’ attitudes toward interprofessional education.” IRB#: 18-010-2. University of Connecticut.

Jun 2017 – Jun 2018

Mitchell M, Aeschlimann JR (Co-PI), Chamberlin KW (Co-PI), Banach D, Marshall JL, Whalley A. “Assessing the impact of chronic opioid use on the severity of C. difficile infections.” IRB#: 17-201-1. UConn Health.

Jun 2017 – Jun 2018

Cavero, S, LaCasse-Kalish R (PI), Dias AB, Chamberlin KW, Gentry A. “Alaris Pump Guardrail Safety.” QA/QI project #: 966. UConn Health.

Sep 2016 – Jun 2017

Likar RM, Palomba JT, Wahl RJ, Chamberlin KW (PI). “Impact of transgender medicine and cultural competency training on pharmacist perceptions of care.” IRB#: 17-043-2. UConn Health.

Sep 2016 – Jun 2017

Mullings LJ, Guynn RS, Jankowski AT, Chamberlin KW (PI). “Evaluating sliding scale insulin use through opinions of correctional prescribers to determine transition to basal bolus therapy practice.” IRB#: 17-044-3. UConn Health.

Page 6: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 6 of 31

Sep 2016 – Jun 2017

Gentry A, Dias AB, Mittal S (Co-PI), Sposito JL, Chamberlin KW (Co-PI). “Assessing the immediate and long-term safety of recombinant tissue plasminogen activator for use in ischemic stroke in patients 80 years and older: a retrospective analysis.” IRB#: 17-037-2. UConn Health.

Aug 2016 – Jun 2017

Whalley A, Salvo M (PI), Levine S, Chamberlin KW, Beaudoin D. “Evaluation of pharmacy involvement in outpatient based transitions of care: assess uptake, quality, and outcomes.” IRB#: 894. UConn Health.

Sep 2015 – Jun 2016

VanHook LJ, Kuszewski GM, LaCasse-Kalish R, Dias A, Chamberlin KW. “Evaluation of a newly implemented pharmacist-driven warfarin collaborative practice: assessing uptake, quality, and outcomes in an inpatient setting.” IRB#: 01-780. UConn Health.

Aug 2015 – Jun 2016

Marshall JL, LaCasse-Kalish R, Kuszewski GM, Seo TH, Chamberlin KW. “Evaluation of a Transitional Care Pharmacist Pilot Program: assessing quality, feasibility, and outcomes on high-risk patient populations.” IRB#: 03-776. UConn Health.

Sep 2014 – Aug 2015

Lemieux S, Rappaport S, LaCasse R, Bunz T, Chamberlin KW(PI). “The influence of antibiotic selection on length of stay in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease: a retrospective study.” IRB#: 15-049-3. UConn Health.

Sep 2014 – Jun 2015

Patel J, Chamberlin KW, Bunz T, Holle L (PI). “An evaluation of the implementation of an oral cancer therapy-monitoring program in metastatic prostate cancer patients taking abiraterone or enzalutamide.” IRB#: 15-045S-3. UConn Health.

Aug 2013 – Jun 2014

Smyth L, Aeschlimann J (PI), Rappaport S, Baker W, Chamberlin K. “Factors related to inappropriate empiric antibiotic treatment of skin and soft tissue infections in the emergency department.” IRB#: 14-054-2. University of Connecticut Health Center.

Aug 2012 – Jun 2013

Chamberlin KW (PI), Rappaport S, Baker W. “Evaluation of a pilot comprehensive, targeted clinical pharmacy service with outpatient follow-up in a high-risk medical population.” IRB#: 13-038-1. University of Connecticut Health Center.

Aug 2012 – Mar 2013

LaCasse R, Chamberlin KW. Medication History Taking at Admission by Pharmacy Students. University of Connecticut Health Center – Department of Pharmacy.

Jun 2011 – May 2012

KnowMyMeds.com and MTM in a private practice setting Utilization of web-based medication adherence software by a clinical pharmacist in a private practice Geriatrics office.

2009 – 2013

Medication Disposal Program Annual medication return program for citizens of Bristol and Southington water districts, in conjunction with the Water Departments and John Dobbins, RPh

Page 7: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 7 of 31

2005 – 2009

Geriatric Outcomes Review In collaboration with Adam Silverman, MD, UCHC Department of Medicine and Jennifer Tan, PharmD Candidate (’07)

Jun 2005 – Mar 2009

Collaborative Center for Clinical Care Improvement (C4I) Pain Subgroup University of Connecticut Health Center

Jul 2003 – Jun 2004

Identifying Risk Factors for Drug Related Problems in the Elderly Patients in the Home Setting

Editorial Activities Editorial Boards & Related Activities 2015 – present Editorial Board, International Journal of General Medicine 2015 Editorial Board, Clinical Pharmacology & Biopharmaceutics 2006 – 2013 Editorial Advisory Board, Geriatric Pharmacy Review.com 2006 – 2010 Customer Service Clinical Liaison, Geriatric Pharmacy Review.com 2004 – 2006 Board of Editors, Geriatric Pharmacy Review.com

American Society of Consultant Pharmacists 2004 – 2011 Assistant Editor, Chapter Newsletter

Connecticut Chapter of the American Society of Consultant Pharmacists 2003 – 2004 Editorial Assistant, Geriatric Pharmacy Review

American Society of Consultant Pharmacists Peer Reviewer 2017 – present Peer Reviewer, Journal of the American Geriatrics Society 2015 – present Peer Reviewer, Journal of the Advanced Practitioner in Oncology 2013 – present Poster Mentor, ASHP Resident Posters 2013 – present Peer Reviewer, University of Connecticut Health Center Pharmacy &

Therapeutics Newsletter 2013 – present Poster & Session Abstract Reviewer, Connecticut Society of Health-System

Pharmacists (CSHP) 2013 – present Peer Reviewer, Pharmacist’s Letter 2012 – present Peer Reviewer, ASHP New Practitioners CV Review Program 2008 – present Peer Reviewer, The Annals of Pharmacotherapy

Page 8: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 8 of 31

2008 – 2009 Peer Reviewer, Annual Meeting Poster Submissions American Society of Consultant Pharmacists

2006 – 2013 Peer Reviewer, Geriatric Pharmacy Review.com 2006 Peer Reviewer, US Pharmacist Publications Book Chapters Chamberlin KW, Salvo M. “Ch. 10: The Use of Dietary Supplements: Focus on Herbal Products.” In: Touhy TA , Jett KF (eds.) Ebersole and Hess’ Toward Healthy Aging, 10th ed. Mosby; 2019. ISBN: 9780323554220 Ehret MJ, Chamberlin KW. “Alzheimer’s Disease case.” In: Katz MD, et al. (eds.) Pharmacotherapy Principles and Practice Study Guide, 5th ed. McGraw-Hill Education/Medical; 2019. Ehret MJ, Chamberlin KW. “Alzheimer’s Disease.” In: Chisholm-Burns MA, et al. (eds.) Pharmacotherapy Principles and Practice, 5th ed. McGraw-Hill Education/Medical; 2019. Ehret MJ, Chamberlin KW. “Alzheimer’s Disease case.” In: Katz MD, et al. (eds.) Pharmacotherapy Principles and Practice Study Guide, 4th ed. McGraw-Hill Education/Medical; 2016. Ehret MJ, Chamberlin KW. “Alzheimer’s Disease.” In: Chisholm-Burns MA, et al. (eds.) Pharmacotherapy Principles and Practice, 4th ed. McGraw-Hill Education/Medical; 2016. Refereed Manuscripts, full-length LeClair JN, Chamberlin KW, Clement J, Holle LM. “Documentation of medical marijuana use in cancer patients.” J Oncol Pharm Practice. 2019;0(0):1-11. DOI: 10.1177/1078155219883912 [PMID: 31707922] White CM, Chamberlin KW, Eisenberg E. “Curcumin, a Turmeric Extract, for Oral Lichen Planus: A Systematic Review.” Oral Diseases. 2019;25:720-25. https://doi.org/10.1111/odi.13034 [PMID: 30614166] Murphy JE, Liles AM, Bingham AL, Chamberlin KW, Dang K, et al. Interprofessional education: Principles and application. An update from the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2018;1-12. https://doi.org/10.1002/jac5.1025 Whalley AS, Salvo MC, Levine SF, Chamberlin KW, Beaudoin D. “Evaluation of Pharmacist Involvement in Outpatient Transitions of Care.” J Gen Intern Med. 30 April 2018;33:1227. DOI: 10.1007/s11606-018-4459-x [PMID: 29713879] Andrews R, Chamberlin KW, Ingrassia J, Kuo CL, Pizzi A, Moriatis-Wolf J. “5 Step Guide to Conversations Between Trainees and Patients in Pain: Educating Trainees about Discontinuing Opioids using a Staged Approach.” J Family Medicine and Community Health. Jul 2017;4(5):1123-27.

Page 9: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 9 of 31

Chamberlin KW, Sahbani O. “Key Cogs in the Management of Parkinson’s Disease.” Drug Topics 2016;160(12):54-64. Patel JM, Holle LM, Clement JM, Bunz T, Niemann C, Chamberlin KW. “Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer.” J Oncol Pharm Practice 2016;22(6):777-83. DOI: 10.1177/1078155215612541 [PMID: 26493871] Ehret MJ, Chamberlin KW. Current practices in the treatment of Alzheimer’s Disease: where is the evidence after the phase III trials? Clinical Therapeutics. 2015 Aug 1;37(8):1604-16. DOI: 10.1016/j.clinthera.2015.05.510 [PMID: 26122885] Chamberlin KW, Baker WL. Benefit-risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients. Clinical Interventions in Aging. 2015;10:733-40. Baker WL, Chamberlin KW. New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics? Clin Pharmacol Ther. 2014 Jul;96(1):17-19. doi: 10.1038/clpt.2014.48. [PMID: 24942397] Baker WL, Smyth LR, Riche DM, Bourret EM, Chamberlin KW, White WB. Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis. J Am Soc Hypertens. 2014 Apr;8(4):262-75. doi: 10.1016/j.jash.2014.01.007. Epub 2014 Jan 26. Review. [PMID: 24602971] Chamberlin KW, Holle LM. “Management of common pain conditions encountered by pharmacists: Osteoarthritis; low back pain; fibromyalgia; sprains, strains, contusions; and generalized headaches.” Drug Topics. August 2013;157(8):48-60. Holle LM, Chamberlin KW. “Regulatory and ethical issues in pain management.” Drug Topics. July 2013;157(7):58-68. Chamberlin KW, Silverman A. “Celecoxib-Associated Anaphylaxis.” The Annals of Pharmacotherapy 2009;43:777-781. DOI 10.1345/aph.1L593 [PMID: 19299321] Chamberlin KW, Cottle M, Neville R, Tan J. “Oral Oxymorphone for Pain Management.” The Annals of Pharmacotherapy. 2007 Jul;41(7):1144-1152. [PMID: 17595308] Refereed Manuscripts, short Long A, Chamberlin KW. “Lefamulin (Xenleta®) for Community Acquired Bacterial Pneumonia.” Drug Topics. 2019;163(XX):xx. Fratoni A, Chamberlin KW. “FDA approves solriamfetol (Sunosi™) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea.” Drug Topics. 2019;163(XX):xx. Wein M, Chamberlin KW. “FDA approves pretomanid for treatment of highly drug resistant tuberculosis.” Drug Topics. 2019;163(9)44. Bogdanska W, Chamberlin KW. “FDA approves cariprazine for treatment of depressive episodes in Bipolar I Disorder.” Drug Topics. 2019;163(8):1. LeClair J, Chamberlin KW. “FDA approves baloxavir marboxil (Xofluza™) for treatment of acute,

Page 10: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 10 of 31

uncomplicated influenza in people 12 years of age and older who have had flu symptoms for no more than 48 hours.” Drug Topics. 2019;163(3):1. Emonds EE, Chamberlin KW. “New Drug Review: FDA approves adexanet alfa (Andexxa™) for reversal agent of factor Xa inhibitors.” Drug Topics. 2018;162(11):1. Patel S, Chamberlin KW. “New Drug Review: FDA approves lofexidine (Lucemyra™) for non-opioid management of opioid withdrawal symptoms.” Drug Topics. 2018;162(10):17. Chamberlin KW, Barrack J. “New Drug Review: FDA approves oral solution cannabidiol/CBD (Epidiolex™).” Drug Topics. 2018;162(9):1. Chamberlin KW, Cavero S. “New Drug Review: FDA approves meropenem and vaborbactam (Vabomere™) for complicated urinary tract infections.” Drug Topics. 2018;162(2):1. Chamberlin KW, Sahbani O. “New Drug Review: Delafloxacin (Baxdela™) for Acute Bacterial Skin Infections.” Drug Topics. 2017;161(12):1. Chamberlin KW, Mitchell M. “New Drug Review: FDA approves edaravone (Radicava™) for the treatment of ALS.” Drug Topics. 2017;161(10):1. Chamberlin KW, Gentry A. “New Drug Report: FDA approves ocrelizumab (Ocrevus™) for the treatment of Multiple Sclerosis.” Drug Topics. 2017;161(8):1. Chamberlin KW, Whalley S. “New Drug Report: FDA approves safinamide (Xadago™) as add-on treatment for patients with Parkinson’s disease.” Drug Topics. 2017;161(6):19. Chamberlin KW, Gentry A. "New Drug Review: FDA approves new chronic hepatitis C treatment – sofosbuvir/velpatasvir (Epclusa™)." Drug Topics. 2016;160(11):31. Chamberlin KW, Whalley AS. “Daclizumab approved (Zinbryta™) for relapsing forms of multiple sclerosis.” Drug Topics 2016;160(11):24. Marshall JL, Chamberlin KW. "New Drug Review: FDA approves new seizure treatment - brivaracetam." Drug Topics. 2016;160(8):34. VanHook LJ, Chamberlin KW. "New Drug Review: FDA approves new PAH treatment - selexipag." Drug Topics. 2016;160(5):2. Marshall JL, Chamberlin KW. "New Drug Review: FDA approves sacubitril/valsartan to treat heart failure." Drug Topics. 2015;159(11):38. VanHook LJ, Chamberlin KW. "New Drug Review: FDA approves eluxadoline to treat IBS-D in adults." Drug Topics. 2015;159(9):38. Patel JM, Chamberlin KW. "New Drug Review: FDA approves antimicrobial to treat two complicated infections (ceftazidime-avibactam)." Drug Topics. 2015;159(7):38. Lemieux SM, Chamberlin KW. "New Drug Review: FDA approves ferric citrate to treat hyperphosphatemia in dialysis patients." Drug Topics. 2015;159(4):33.

Page 11: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 11 of 31

Chamberlin KW. “New Drug Review: FDA approves new extended-release oxycodone combo.” Drug Topics. 2014;158(12):38. Chamberlin KW. “New Drug Review: FDA approves droxidopa to treat neurogenic orthostatic hypotension.” Drug Topics. 2014;158(8):38. Chamberlin KW. “New Drug Review: Breo Ellipta: a new fixed-dose inhalation combination for patients with COPD.” Drug Topics. 2014;158(5):32, 46. Chamberlin KW. “New Drug Review: New SSRI for depression now available in pharmacies - Brintellix (vortioxetine).” Drug Topics. 2014;158(2):62-63. Chamberlin KW. “FDA approves 4PCC for acute major bleeding.” Drug Topics. 2013;157(11):33,49. Chamberlin KW. “New molecular entity: Kcentra (Prothrombin complex concentrate (human)).” Formulary Journal. Nov 8, 2013. (http://formularyjournal.modernmedicine.com) Chamberlin KW. “New molecular entity: Tecfidera (dimethyl fumarate).” Formulary. 2013;48:256-57. Chamberlin KW. “New Drug Review: FDA approves third oral agent for MS – dimethyl fumarate.” Drug Topics. August 2013;157(8):46. Online Education, peer-reviewed Holle L, Pham T, Chamberlin KW. “Acute Low Back Pain and Clinical Considerations in Opioid Therapy.” Drug Topics. 2014 Aug. Part 2 of an online interactive case at: http://pharmacyce.uconn.edu/PainCase2/story.html Chamberlin KW, Holle L, Pham T. “Osteoarthritis and Headache.” Drug Topics. 2014 Jul. Part 1 of an online interactive case at: http://pharmacyce.uconn.edu/PainCase1/story.html Chamberlin KW. “Problems related to the patient’s response to therapy.” Geriatric Pharmacy Review.com 4.04;2012. Chamberlin KW. “Problems related to the administration of therapy.” Geriatric Pharmacy Review.com 4.03;2012. Chamberlin KW. “Problems based on choice of therapy.” Geriatric Pharmacy Review.com 4.02;2012. Chamberlin KW. “Medication therapy problems.” Geriatric Pharmacy Review.com 4.01;2012. Chamberlin KW. “Documenting the pharmaceutical health plan.” Geriatric Pharmacy Review.com 3.04;2012. Chamberlin KW. “Devising a therapeutic monitoring plan.” Geriatric Pharmacy Review.com 3.03;2012. Chamberlin KW. “Designing a therapeutic regimen.” Geriatric Pharmacy Review.com 3.02;2012. Chamberlin KW. “Therapeutic care planning.” Geriatric Pharmacy Review.com 3.01;2012.

Page 12: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 12 of 31

Chamberlin KW. “Laboratory tests and their interpretation.” Geriatric Pharmacy Review.com 2.04;2012. Chamberlin KW. “Functional, cognitive, and affective assessment of the elderly.” Geriatric Pharmacy Review.com 2.03;2012. Chamberlin KW. “Physical examination of the elderly.” Geriatric Pharmacy Review.com 2.02;2012. Chamberlin KW. “The geriatric health history.” Geriatric Pharmacy Review.com 2.01;2012. Chamberlin KW. “End-of-life issues.” Geriatric Pharmacy Review.com 1.09;2012. Chamberlin KW. “Pharmacokinetic and pharmacodynamic interactions.” Geriatric Pharmacy Review.com 1.08;2012. Chamberlin KW. “Physiological aspects of aging.” Geriatric Pharmacy Review.com 1.07;2012. Chamberlin KW. “Social and psychological issues in geriatrics.” Geriatric Pharmacy Review.com 1.06;2012. Chamberlin KW. “Ethical issues in geriatrics.” Geriatric Pharmacy Review.com 1.05;2012. Chamberlin KW. “Communicating with the elderly.” Geriatric Pharmacy Review.com 1.04;2012. Chamberlin KW. “Continuum of care.” Geriatric Pharmacy Review.com 1.03;2012. Chamberlin KW. “Wellness and geriatric health promotion.” Geriatric Pharmacy Review.com. 1.02;2012. Chamberlin KW. “Basic concepts in geriatric pharmacy.” Geriatric Pharmacy Review.com. 1.01;2012. Chamberlin KW. “Drug-induced skin disorders.” Geriatric Pharmacy Review.Com: 6.04;2009. Logan JK, Chamberlin KW. “Vascular lesions, blistering diseases, and neoplasms.” Geriatric Pharmacy Review.Com: 6.03; 2009. Logan JK, Chamberlin KW. “Inflammatory skin disorders that affect the elderly.” Geriatric Pharmacy Review.Com: 6.02; 2009. Chamberlin KW. “Age-related skin changes and pressure ulcers.” Geriatric Pharmacy Review.Com: 6.01;2009. Chamberlin KW. “Update: Sleep Disorders in the Elderly.” GeriatricPharmacyReview.Com: 16.03; 2007. Jeffery SM, Chapron DJ, Chamberlin KW. “Laboratory Tests and Their Interpretation.” Original author: Knight T. GeriatricPharmacyReview.com: 2.04;2005. Jeffery SM, Chapron DJ, Chamberlin KW. “Functional, Cognitive, and Affective Assessment of the Elderly.” Original author: Knight T. GeriatricPharmacyReview.com: 2.03;2005.

Page 13: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 13 of 31

Jeffery SM, Chapron DJ, Chamberlin KW. “Physical Examination of the Elderly.” Original author: Knight T. GeriatricPharmacyReview.com: 2.02;2005. Jeffery SM, Chapron DJ, Chamberlin KW. “The Geriatric Health History.” Original author: Knight T. GeriatricPharmacyReview.com: 2.01;2005. Chamberlin KW. “An Update to ‘Menopause and Hormone Replacement Therapy.’” Original authors: Jeffery SM, Chamberlin KW. GeriatricPharmacyReview.com: 7.6;2005. Chamberlin KW, Pham TP, Jeffery SM. “Pain Management and End of Life Care.” GeriatricPharmacyReview.Com: 12.08; 2004. Chamberlin KW, Jeffery SM. “Sleep Disorders in the Elderly.” GeriatricPharmacyReview.Com: 16.03; 2003. Jeffery SM, Chamberlin KW. “Menopause and Hormone Replacement Therapy.” GeriatricPharmacyReview.Com: 7.6; 2003. Pocket References Kuszewski G, Chamberlin KW, Kalish R. “Pocket Reference for Opioid Management of Pain, v5.0.” UCHC-JDH Department of Pharmacy & UConn School of Pharmacy, March 2016. Kuszewski G, Chamberlin KW, Kuntz J, et al. “Pocket Reference for Opioid Management of Pain, v4.0.” UCHC-JDH Department of Pharmacy & UConn School of Pharmacy, April 2015. Chamberlin KW, LaCasse R, Metcalf K, Pizzoferrato T, Holle L. “Pocket Reference for Pain Management, v3.0.” UCHC-JDH Department of Pharmacy & UConn School of Pharmacy, March 2013. Farino DE, Chamberlin KW. Pharmacotherapy Clinical Pearls. University of Connecticut Health Center, Department of Medicine, November 2011. Chamberlin KW, LaCasse R, Bunick P, et al. “Pocket Reference for Pain Management, v2.0.” UCHC-JDH Department of Pharmacy & UConn School of Pharmacy, September 2011. Chamberlin KW. “Pain Patient Education Guide.” Collaborative Center for Clinical Care Improvement (C4I) Pain & Palliative Care Subgroup, University of Connecticut Health Center, 2007. Chamberlin KW. “Pocket Reference for Pain Management.” Collaborative Center for Clinical Care Improvement (C4I), University of Connecticut Health Center, 2005. Chamberlin KW. “Dementia and Alzheimer’s Management Info Card.” MED-PASS, Inc., 2005. Pytlarz A, Chamberlin KW. “Medications and their relationship to Meals Info Card.” MED-PASS, Inc., 2005.

Page 14: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 14 of 31

Posters Dec 2019 Bogdanska W, Holle LM, Moran A, LeClair JN, Chamberlin KW. “Oncology

pharmacist involvement during patient visits increases adherence to laboratory monitoring and medication adherence.” ASHP Midyear Clinical Meeting, Las Vegas, NV.

Dec 2019 Wein ME, Aeschlimann JR, Banach DB, Johnston SJ, Chamberlin KW,

Barrack JG. “Implementation of a C. diff secondary prophylaxis protocol in an academic medical center.” ASHP Midyear Clinical Meeting, Las Vegas, NV.

Dec 2019 Fratoni AJ, Banach DB, Chamberlin KW, Kuszewski GM, Patel S.

“Assessment of automated antibiotic timeout on broad-spectrum antibiotic usage.” ASHP Midyear Clinical Meeting, Las Vegas, NV.

Dec 2019 Long A, Czerwinski J, Rizal A, Kolodziej M, Emonds EE, Chamberlin KW.

“Utilization of pharmacy student trainees to assist with patient discharge education on oral anticoagulation therapy.” ASHP Midyear Clinical Meeting, Las Vegas, NV.

Oct 2019 Andrews R, Chamberlin KW, Ozimek J, Katz M, Rao S. “Technology to

Teach: Meeting Chronic Pain Needs of Primary Care.” Alliance for Academic Internal Medicine – APDIM Fall Meeting. Denver, CO.

Apr 2019 Katz M, Andrews R, Hilario H, Chamberlin KW, Barrack J. “Aligning opioid

prescribing practices at an academic health center.” American College of Physicians Annual Meeting, Philadelphia, PA.

Dec 2018 Deneff M, Kalish R, Chamberlin KW. “Evaluation of nursing pain

assessment, medication administration, and documentation for patients on HYDROmorphone.” ASHP Midyear Clinical Meeting, Anaheim, CA.

Dec 2018 Patel S, Johnston S, Kuszewski G, Sahbani O, Chamberlin KW. “Compliance

audit of titratable continuous infusions in the critical care unit at a tertiary care academic medical center.” ASHP Midyear Clinical Meeting, Anaheim, CA.

Dec 2018 Barrack J, Chamberlin KW, Andrews R, Katz M, Hilario H, Mitchell M.

“Impact of educational interventions for providers on appropriate prescribing and monitoring of patients on long-term opioid pain management.” ASHP Midyear Clinical Meeting, Anaheim, CA.

Dec 2018 Emonds EE, Salvo MC, Chamberlin KW, Cavero SM. “Impact of

pharmacist’s intervention with proton pump inhibitor (PPI) prescribing and deprescribing in a primary care setting.” ASHP Midyear Clinical Meeting, Anaheim, CA.

Dec 2018 LeClair JN, Holle L, Chamberlin KW, Clement J. “Documentation of medical

marijuana use in cancer patients.” ASHP Midyear Clinical Meeting, Anaheim, CA.

Page 15: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 15 of 31

Nov 2018 Katz M, Andrews R, Hilario H, Chamberlin KW, Barrack J. “From the Ground Up: Leveraging Resident Clinic Policy to Transform Opioid Prescribing Practices at an Academic Medical Center.” UConn School of Nursing Pain Symposium.

Oct 2018 Katz M, Andrews R, Hilario H, Chamberlin KW, Barrack J. “From the

Ground Up: Leveraging Resident Clinic Policy to Transform Opioid Prescribing Practices at an Academic Medical Center.” Alliance for Academic Internal Medicine – APDIM Fall Meeting, Orlando, FL.

Dec 2017 Cavero SM, Kalish R, Dias A, Chamberlin KW, Gentry A. “Reviewing smart

pump analytics to improve medication at the point of care.” 9-041. ASHP Midyear Clinical Meeting, Orlando, FL.

Dec 2017 Sahbani O, Kuszewski G, Banach DB, Aeschlimann JR, Chamberlin KW.

“Financial and clinical impact of nasal methicillin resistant Staphylococcus aureus polymerase chain reaction swab in adults with pneumonia.” 9-036. ASHP Midyear Clinical Meeting, Orlando, FL.

Dec 2017 Mitchell MT, Aeschlimann JR, Chamberlin KW, Banach DB, Czerwinski JL,

Whalley AS. “Assessing the impact of outpatient opioid use on the severity of Clostridium difficile infections: a retrospective study.” 9-040. ASHP Midyear Clinical Meeting, Orlando, FL.

Jul 2017 Carroll DG, Bingham AL, Chamberlin KW, Mohammad RA, Williams N.

“Interprofessional education (IPE) activities at colleges and schools of pharmacy in the United States (US).” American Association of Colleges of Pharmacy (AACP) Annual Meeting, Nashville, TN.

Dec 2016 Likar RM, Palomba JT, Wahl RJ, Chamberlin KW (PI). “Impact of

transgender medicine and cultural competency training on pharmacist perceptions of care.” ASHP Midyear Clinical Meeting, Las Vegas, NV.

Dec 2016 Mullings LJ, Guynn RS, Jankowski AT, Chamberlin KW (PI). “Evaluating

sliding scale insulin use through opinions of correctional prescribers to determine transition to basal bolus therapy practice.” ASHP Midyear Clinical Meeting, Las Vegas, NV.

Dec 2016 Gentry A, Dias AB, Mittal, S (Co-PI), Sposito JL, Chamberlin KW (Co-PI).

“Assessing the immediate and long-term safety of recombinant tissue plasminogen activator for use in ischemic stroke in patients 80 years and older: a retrospective analysis.” ASHP Midyear Clinical Meeting, Las Vegas, NV.

Dec 2016 Whalley A, Salvo M (PI), Levine S, Chamberlin KW, Beaudoin D. “Evaluation

of pharmacy involvement in outpatient based transitions of care: assess uptake, quality, and outcomes.” ASHP Midyear Clinical Meeting, Las Vegas, NV.

Apr 2016 Boafo W, LaCasse-Kalish R, Aeschlimann JR, Chamberlin KW.

“Implementation of Pharmacist-Driven HAART Medication Safety Program at John Dempsey Hospital / UConn Health.” University of Hartford ENPH Day, West Hartford, CT.

Page 16: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 16 of 31

Dec 2015 VanHook LJ, Kuszewski G, LaCasse-Kalish R, Dias A, Chamberlin KW. “Evaluation of a newly implemented pharmacist-driven warfarin collaborative practice: assessing uptake, quality, and outcomes in an inpatient setting.” ASHP Midyear Clinical Meeting, New Orleans, LA.

Dec 2015 Marshall JL, LaCasse-Kalish R, Kuszewski G, Seo TH, Chamberlin KW.

“Evaluation of a Transitional Care Pharmacist Pilot Program: assessing quality, feasibility, and outcomes on high-risk patient populations.” ASHP Midyear Clinical Meeting, New Orleans, LA.

Dec 2014 Patel J, Chamberlin KW, Bunz T, Holle L (PI). "An evaluation of the

implementation of an oral cancer therapy-monitoring program in metastatic prostate cancer patients taking abiraterone or enzalutamide." ASHP Midyear Clinical Meeting, Anaheim, CA.

Dec 2014 Lemieux S, Rappaport S, LaCasse R, Bunz T, Chamberlin KW(PI). "The

influence of antibiotic selection on length of stay in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease: a retrospective study." ASHP Midyear Clinical Meeting, Anaheim, CA.

Dec 2013 Bourret EM, Smyth LR, Riche DM, Chamberlin KW, Baker WL (PI). “Effect

of sodium-glucose contransporter 2 inhibitors on blood pressure: a meta-analysis.” ASHP Midyear Clinical Meeting, Orlando, Florida.

Dec 2013 Smyth L, Aeschlimann J (PI), Rappaport S, Baker W, Chamberlin K. “Factors

related to inappropriate empiric antibiotic treatment of skin and soft tissue infections in the emergency department.” ASHP Midyear Clinical Meeting, Orlando, Florida.

Dec 2012 Rappaport S, Chamberlin KW (PI), Baker W. “Evaluation of a pilot

comprehensive, targeted clinical pharmacy service with outpatient follow-up in a high-risk medical population.” ASHP Midyear Clinical Meeting, Las Vegas, Nevada.

Sept 2012 Chamberlin KW, Buckley TE, Dobbins JC. “A Prescription for Clean Water

and Safer Homes: Medication Disposal Program.” New England Pharmacists Convention, Mashantucket, Connecticut.

Nov 2003 Jeffery SM, Huie-Li A, Desilet A, Chamberlin KW. “Identifying Risk Factors

for Drug Related Problems in the Elderly Patients in the Home Setting.” American Society of Consultant Pharmacists (ASCP) National Meeting, San Antonio, Texas.

Oct 2003 Musial B, Wilkosz MF, Chamberlin KW. “Strategic Management of Drug

Shortages.” Connecticut Society of Health Systems Pharmacists (CSHP) “Catch the Wave Meeting,” Meriden, Connecticut.

Institutional Drug Monographs Erhard L, Liu S, Rappaport S, Chamberlin KW. Apixaban (Eliquis®) Drug Monograph. UCHC-JDH Pharmacy & Therapeutics Committee, April 2013.

Page 17: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 17 of 31

Kilcoyne D, Kozubal K, Machir D, Chamberlin KW. Tapentadol oral immediate release tablets (Nucynta™) Drug Monograph. UCHC-JDH Pharmacy & Therapeutics Committee, July 2009. Naka A, Otaluka J, Patel R. Chamberlin KW. Fesoterodine extended release tablets (Toviaz™) Drug Monograph. UCHC-JDH Pharmacy & Therapeutics Committee, June 2009. Baker M, Nalepa C, Chamberlin KW. Rufinamide (Banzel®) Drug Monograph. UCHC-JDH Pharmacy & Therapeutics Committee, April 2009. Bonczek S, Koruni J, Chamberlin KW. Lacosamide (Vimpat®) Drug Monograph. UCHC-JDH Pharmacy & Therapeutics Committee, April 2009. Podgorski A, Nalepa C, Oteng G, Chamberlin KW. Alvimopan (Entereg®) Drug Monograph. UCHC-John Dempsey Hospital P&T Formulary, December 2008. Chamberlin KW, Logan JK, Lee SE, Hooker S. “Methylnaltrexone (Relistor™) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, September 2008. Chamberlin KW, Fam P, Campanelli L. “Nebivolol (Bystolic®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, March 2008. Chamberlin KW, Jordan S, Zanger G. “Doripenem (Doribax®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, March 2008. Chamberlin KW, Gervasi D, Nowicki M, Zanger G. “Aliskiren (Tekturna®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, September 2007. Neville R, Bhalodi P, Szewczyk M, Talati R, Chamberlin KW. “Fentanyl Citrate Buccal Tablet (Fentora ®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, April 2007. Myers K, Bissonnette C, Boulier R, Ciliberto A, Chamberlin KW. “Anidulafungin (Eraxis™) for Injection Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, March 2007. Watson K, Zaky S, Zembrowski B, Zhaky T, Chamberlin KW. “Paliperidone (Invega™) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, February 2007. Mills N, Lucey H, Cho S, Morrone J, Chamberlin KW. “Sitagliptin (Januvia®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, January 2007. Moniz C, Myers KM, Watson K, Chamberlin KW. “Lidocaine and Tetracaine 70 mg Topical Patch (Synera™) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, September 2006. Cottle M, Neville R, Tan J, Chamberlin KW. “Oxymorphone and Oxymorphone ER (Opana™) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, July 2006. Tesell M, Voisine J, Yen N, Chamberlin KW. “Varenicline (Chantix™) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, June 2006. Burgess J, Chen J, Zoob P, Duff R, Chamberlin KW. “Insulin glulisine (Apidra™) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, April 2006.

Page 18: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 18 of 31

Luciano S, Duff R, Chamberlin KW. “1% sodium hyaluronate (Euflexxa™) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, April 2006. Gilmore L, Montanez D, Rovaldi A, Chamberlin KW. “Ziconotide (Prialt®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, February 2006. Burkman G, Collins T, Perrault S, Chamberlin KW. “Pregabalin (Lyrica®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, January 2006. Tan J, Chamberlin KW. “Ramelteon (Rozerem™) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, December 2005. Luciano S, Pandya L, Parikh J, Chamberlin KW. “Pramlintide (Symlin®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, November 2005. Augello M, Marshall SA, Stafford K, Chamberlin KW. “Exenatide (Byetta®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, October 2005. Mohamed A, Shah A, Lucivero L, Chamberlin KW. “Tegaserod (Zelnorm®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, July 2005. Fox C, Broad K, Morasutti J. “Eszopiclone (Lunesta®) Drug Monograph.” UCHC-JDH Pharmacy & Therapeutics Committee, June 2005. Agency Drug Use Evaluations Chamberlin KW, Wrabel MG, Baker B. Drug Utilization Evaluation: Associated Risks of Antipsychotic Use in an Elderly Patient Population. River Valley Services, Middletown, CT, June 2010. Chamberlin KW, Wrabel MG, Baker B. Drug Utilization Evaluation: Gabapentin in Anxiety Disorders and Bipolar Disorders. River Valley Services, Middletown, CT, December 2009. Invited Presentations Dec 20, 2019 Chamberlin KW. “Methadone as an analgesic.” Project ECHO. 1-hour CME

webinar. Dec 12, 2019 Chamberlin KW, Andrews R. “Non-opioid analgesic options for chronic

pain.” CT Comprehensive Pain Center. 0.5-hour webinar. Nov 25, 2019 Chamberlin KW. “Best Practices for Opioid Tapering.” CT Comprehensive

Pain Center. 0.5-hour webinar. Nov 15, 2019 Chamberlin KW. “Best Practices for Opioid Tapering.” Project ECHO. 1-

hour CME webinar.

Page 19: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 19 of 31

Oct 28, 2019 Andrews R, Chamberlin KW. “Pain Management: Using Guidelines and Best Practices.” CT Comprehensive Pain Center. 0.5-hour webinar.

Oct 18, 2019 Andrews R, Chamberlin KW, Ozimek J. “Developing a Clinic-Based,

Multidisciplinary Chronic Pain Management Curriculum for Trainees.” Alliance for Academic Internal Medicine – APDIM Fall Meeting. Denver, CO. 1.5-hour CME workshop.

Oct 8, 2019 Andrews R, Chamberlin KW. “How to have difficult conversations and

manage a patient’s pain.” Internal Medicine Residency, UConn Health. 4-hour workshop.

Sept 18, 2019 Andrews R, Chamberlin KW. “How to have difficult conversations and

manage a patient’s pain.” Internal Medicine Residency, UConn Health. 4-hour workshop.

Sept 5, 2019 Andrews R, Chamberlin KW. “Lo-tech Training for High-Quality

Evaluations.” Internal Medicine Residency, UConn Health. 3-hour workshop. June 26, 2019 Chamberlin KW. “Breaking down barriers for opioid use disorder.”

McKesson ideaShare 2019. Orlando, FL. 1.5-hour CE lecture. June 21, 2019 Chamberlin KW. “Non-Opioid and Non-NSAID options to achieve

analgesia.” Project ECHO. 1.5-hour CME lecture. Apr 13, 2019 Andrews R, Fortin A, Chamberlin KW. “Communicating Effectively When

You Don’t Want To: practical strategies for difficult conversations with patients, staff, administrators, and other clinicians.” American College of Physicians Internal Medicine Meeting 2019. Philadelphia, PA. Two (#2), 1.5-hour CMEs.

Mar 26, 2019 Andrews R, Baldwin J, Nardino R, Chamberlin KW. “Lo-tech Training for

High-Quality Evaluations.” Internal Medicine Residency, UConn Health. 3-hour workshop.

Mar 6, 2019 Emonds E, Chamberlin KW. “BEERS Criteria – what you want to know

about meds that may potentially cause adverse drug events in older adults.” NICHE Quarterly Meeting. UConn Health. 1-hour CNE lecture.

Feb 26, 2019 Andrews R, Baldwin J, Nardino R, Chamberlin KW. “Lo-tech Training for

High-Quality Evaluations.” Internal Medicine Residency, UConn Health. 3-hour workshop.

Feb 15, 2019 Chamberlin KW. “Opioids and CNS Depressants: a dangerous cocktail.”

Project ECHO. 1.5-hour CME lecture. Dec 2, 2018 Chamberlin KW, Andrews R. “Five Stages to Discontinuing Opioids: having

conversations to de-escalate, discontinue, or deprescribe opioids for chronic pain.” ASHP Midyear Clinical Meeting 2018. Anaheim, CA. 1.25-hour CE.

Nov 16, 2018 Kim K, Chamberlin KW. “Eliciting the Pain Story: what to ask.” Project

ECHO. 1.5-hour CME lecture.

Page 20: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 20 of 31

Nov 13, 2018 Chamberlin KW. “Opioids & Clinical Conversations: a pharmacist’s guide to

effective pain management consultations.” Connecticut Pharmacists Association. Shelton, CT. 1-hour CE.

Oct 26, 2018 Andrews R, Baldwin J, Nardino R, Chamberlin KW. “Lo-tech Training for

High-Quality Evaluations.” Alliance for Academic Internal Medicine (AAIM) - 2018 APDIM Fall Meeting. Orlando, FL. 1.25-hour CME.

Oct 23, 2018 Chamberlin KW. “Opioids & Clinical Conversations: a pharmacist’s guide to

effective pain management consultations.” McKesson Stakeholders Annual Meeting. Pittsburgh, PA. 1-hour CE lecture.

Sep 28, 2018 Chamberlin KW. “Pearls for Challenging Trainees: the audible playbook for

trainee challenges.” Preceptor Bootcamp 2018. UConn School of Pharmacy Storrs, CT. 1-hour CE.

Sep 13, 2018 Chamberlin KW. “The Pharmacist’s Role in Treating and Managing

Migraines.” New England Pharmacists Convention. Foxwoods Resort. 1-hour CE lecture.

Aug 17, 2018 Kim K, Chamberlin KW. “Best Practices in Chronic Pain Management and

Opioid Prescribing: overview of guidelines.” Project ECHO. 1.5-hour CME lecture.

Aug 16, 2018 Chamberlin KW, Andrews R. “The Pendulum of Pain Management: using

guidelines and best practices at UConn Health.” UConn Health Medical Grand Rounds. 1-hour CME lecture.

Jul 16, 2018 Chamberlin KW, Andrews R. “Five Stages to Discontinuing Opioids:

Conversations to de-escalate, discontinue, or deprescribe opioids for chronic pain.” 2018 Opioid Epidemic Forum. National Harbor, MD. 0.75-hour CME lecture.

Jul 8, 2018 Chamberlin KW. “Opioids & Clinical Conversations: a pharmacist’s guide to

effective pain management consultations.” McKesson ideaShare 2018. Las Vegas, NV. 1-hour CE lecture.

Oct 20, 2017 Chamberlin KW, Andrews R. “Five Stages to Discontinuing Opioids:

Conversations to de-escalate, discontinue, or deprescribe opioids for chronic pain.” 2017 Opioid Epidemic Forum. Scottsdale, AZ. 0.75-hour CME lecture.

Oct 10, 2017 Andrews R, Chamberlin KW. “Chronic Pain Management for Primary Care

Physicians.” Internal Medicine Residency Program – Clinical Practice Colloquia [40 residents]. UConn Health. 3.5-hour lecture.

Sept 14, 2017 Chamberlin KW. “Current and Emerging Therapies in Multiple Sclerosis.”

New England Pharmacists Convention. Foxwoods Resort. 1-hour CE lecture. Sep 12, 2017 Andrews R, Chamberlin KW. “Chronic Pain Management for Primary Care

Physicians.” Internal Medicine Residency Program – Clinical Practice Colloquia [40 residents]. UConn Health. 3.5-hour lecture.

Page 21: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 21 of 31

Mar 11, 2017 Andrews R, Chamberlin KW. “Five-Step Guide to Conversations Between

Trainees and Patients in Pain.” Council of Faculty and Academic Societies (CFAS) and Organization of Resident Representatives (ORR) Spring Meeting, Orlando, FL. 1-hour CME lecture.

Dec 16, 2016 Chamberlin KW. “CDC Guideline for Prescribing Opioids for Chronic Pain.”

UConn School of Pharmacy Henry A. Palmer CE Finale 2016. Rocky Hill, CT. 1-hour CE lecture.

Nov 16, 2016 Chamberlin KW. “Update to the Beers Criteria – a guide for use to the AGS

2015 Beers Criteria.” Connecticut Pharmacists Association Hot Topics in Geriatrics Continuing Education Conference. Trumbull, CT. 1-hour CE lecture.

Nov 3, 2016 Chamberlin KW. “Update to the Beers Criteria.” Medical Grand Rounds,

UConn John Dempsey Hospital / UConn Health. 1-hour CME lecture. Jun 1, 2016 Chamberlin KW. “CT-Based General Residency and Fellowship Informational

Session.” University of Saint Joseph School of Pharmacy. 2-hour panel discussion.

Apr 14, 2016 Huey L, Chamberlin KW, Andrews R, Little B, Bleecher K, Mintz C. “Opioid

Overdose Epidemic: response across the UConn continuum in UME, GME, and CME.” Medical Education Grand Rounds. UConn Health. 1-hour CE lecture.

Nov 13, 2015 Chamberlin KW, Hobbs L, Neville-Curtin R. “Becoming an Effective

Preceptor: Transitioning from Student and Resident to Preceptor.” 9th Annual Greg Gousse Connecticut Residency Conference. Coco Key Conference Center, Waterbury, CT. 1-hour CE lecture.

Jul 31, 2015 Chamberlin KW. 2015 Update in Geriatric Pharmacology: Prescribing

Medications in Older Adults. UConn Center on Aging Summer Geriatrics Conference. UConn Health. 1-hour lecture.

Jun 11, 2015 Andrews R, Chamberlin KW. “Chronic Pain Management for Primary Care

Physicians.” Internal Medicine Residency Program – Clinical Practice Colloquia [4 residents]. UConn Health. 1.5-hour lecture.

Mar 19, 2015 Andrews R, Chamberlin KW. “Chronic Pain Management for Primary Care

Physicians.” Internal Medicine Residency Program – Clinical Practice Colloquia [7 residents]. UConn Health. 1.5-hour lecture.

Feb 19, 2015 Andrews R, Chamberlin KW. “Chronic Pain Management for Primary Care

Physicians.” Internal Medicine Residency Program – Clinical Practice Colloquia [8 residents]. UConn Health. 1.5-hour lecture.

Jan 22, 2015 Andrews R, Chamberlin KW. “Chronic Pain Management for Primary Care

Physicians.” Internal Medicine Residency Program – Clinical Practice Colloquia [8 residents]. UConn Health. 1.5-hour lecture.

Page 22: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 22 of 31

Dec 18, 2014 Chamberlin KW. “New Drugs of 2014.” Medical Grand Rounds – John Dempsey Hospital / UConn Health. 1-hour CME lecture.

Oct 30, 2014 Andrews R, Chamberlin KW. “Chronic Pain Management for Primary Care

Physicians.” Internal Medicine Residency Program – Clinical Practice Colloquia [9 residents]. UConn Health. 1.5-hour lecture.

Oct 20, 2014 Bennett T, Chamberlin KW. “Narcotic Addiction and Treatment.” National

Primary Care Week Lunch & Learn Session. UConn Health (broadcast state-wide). 0.5-hour lecture.

Sep 4, 2014 Andrews R, Chamberlin KW. “Chronic Pain Management for Primary Care

Physicians.” Internal Medicine Residency Program – Clinical Practice Colloquia [8 residents]. UConn Health. 1.5-hour lecture.

Aug 8, 2014 Chamberlin KW. 2014 Update in Geriatric Pharmacology. UConn Center on

Aging Summer Geriatrics Conference. UConn Health. 1-hour lecture. Jun 4, 2014 Chamberlin KW. CT-Based General Residency and Fellowship Informational

Session. University of Saint Joseph School of Pharmacy. 2-hour panel discussion.

Apr 23, 2014 Chamberlin KW, Teevan C, Armstrong P, Shuster K. “Careers in hospital and

health systems pharmacy.” Lunch ‘n Learn series, University of Connecticut School of Pharmacy. 1-hour panel discussion.

Apr 8, 2014 Chamberlin KW. ASHP Residency Informational Session. University of

Connecticut School of Pharmacy. 2-hour panel discussion. Feb 6, 2014 Chamberlin KW. “Exploring the expanded treatment armamentarium for

Multiple Sclerosis.” Connecticut Pharmacists Association (CPA) Midwinter Conference. Southington, CT. 1-hour CE lecture.

Dec 19, 2013 Chamberlin KW, Baker WL. “New Drugs and Old Drugs: a 2013 update”.

UCHC-JDH Medical Grand Rounds. 1-hour CME lecture. Sept 26, 2013 Chamberlin KW, Smyth L. Seniors and medications. AHEPA Senior Housing.

Wethersfield, CT. 1-hour talk. July 19, 2013 Chamberlin KW. Drug Interactions Revealed: a review of CYP450 drug-drug

interactions. UConn Center on Aging Geriatric Summer Series. University of Connecticut Health Center. 1-hour lecture.

Jun 5, 2013 Chamberlin KW. CT-Based General Residency and Fellowship Informational

Session. University of Saint Joseph School of Pharmacy. 2-hour panel discussion.

Mar 22, 2013 Chamberlin KW, Rappaport SH. “Drug Interactions Revealed: a review of

CYP450 interactions and other complex drug-drug interactions.” Greater Hartford Nephrology Conference. University of Connecticut Health Center. 2-hour lecture.

Page 23: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 23 of 31

Jan 4, 2013 Chamberlin KW. “An Overview of Pain Management in the OB/GYN Environment.” UCHC-JDH Labor and Delivery Grand Rounds. 1-hour lecture.

Nov 15, 2012 Chamberlin KW, Baker WL. “New Drugs and Old Drugs: a 2012 update”.

UCHC-JDH Medical Grand Rounds. 1-hourCME lecture. Jun 22, 2012

Chamberlin KW. “Pain Management in Renally Impaired Individuals.” Greater Hartford Nephrology Conference. University of Connecticut Health Center. 2-hour lecture.

Jun 12, 2012

Chamberlin KW. “Sleep Medications in the Elderly.” VA Connecticut APRN Conference. VA Connecticut – West Haven. 1-hour lecture.

Apr 13, 2012 Chamberlin KW. “Hypnotics’ association with mortality or cancer.” Center on

Aging Education Rounds, University of Connecticut Health Center. ½-hour lecture.

Feb 28, 2012 Chamberlin KW. “Pain Management in the Renally Impaired.” Nephrology

Grand Rounds, University of Connecticut Health Center. 1-hour lecture. Dec 14, 2011 Chamberlin, KW. “Medication Management in the Elderly.” Duncaster

Lifecare Community, Bloomfield, CT. 1-hour presentation. Nov 17, 2011 Chamberlin KW, Baker WL. “Drug Update: 2011”. UCHC-JDH Medical

Grand Rounds. 1-hour CME lecture. Nov 7, 2011 Chamberlin KW. “B v G: where medicine and politics are trying to mix.” CT-

ASCP Continuing Education Program, Masonicare – Wallingford, CT. 1-hour CE lecture.

Oct 20, 2011 Park HS, Kim MH, Chamberlin KW. “Safe Medication Practice.”

Connecticut Center for Healthy Aging, THOCC – Bradley Campus. 1-hour lecture.

Jul 15, 2011 Chamberlin KW. “New Drugs and FDA Label Changes for Meds for Older

Adults.” UConn Health Center Update in Geriatric Medicine Summer Series – 25th Anniversary. 1.25 hour lecture.

Apr 7, 2011 Chamberlin KW, White CM, Barber A. “Ask the Pharmacist – Know your

medications.” The Tribune Company - Parent Company to the Hartford Courant. Webcast discussion, 1-hour.

Dec 15, 2010 Chamberlin KW. “Overview and Management of Metabolic Side Effects of

Atypical Antipsychotics.” Riverview Children’s Hospital: Psychiatry Grand Rounds. 1-hour CE/CME lecture.

Apr 9, 2010 Chamberlin KW. “A Case Study in Chronic Low Back Pain: Pain management

with skeletal muscle relaxants and non-opioid analgesics” Senior Symposium ’10, MGM Foxwoods Resort. 1-hour CE lecture.

Page 24: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 24 of 31

Jun 26, 2009 Chamberlin KW. “Proceed With Caution: A review of drug-drug interactions in the elderly” University of Connecticut Center on Aging. 2-hour lecture.

Jun 11, 2009 Baccaro N, Chamberlin KW, Civetta J. “Pain and Palliative Care: the Where,

When, and How with open Q&A.” UCHC-JDH Medical Grand Rounds, Session 3 of 3. 1-hour open discussion board with audience between all 3 speakers.

Jun 4, 2009 Chamberlin KW. “Pain and Palliative Care: The WHO and What of Pain

Management.” UCHC-JDH Medical Grand Rounds, Session 2 of 3. Content developer and speaker for 1-hour CME lecture.

May 28, 2009 Civetta J, Chamberlin KW, Baccaro N. “Pain and Palliative Care: the AIRS

Q&A”. UCHC-JDH Medical Grand Rounds, Session 1 of 3. Content developer; Civetta presented 1-hour CME lecture.

Feb 7, 2008 Chamberlin KW. “Handheld Applications at the Point-of-Care.” University

of Connecticut School of Medicine, 2nd year Medical Students – CMPS Case Studies.

Mar 2007 Chamberlin KW. “Patient-Controlled Analgesia.” University of Connecticut

School of Medicine: 3rd year Medical Students Neuroscience Homeweek. Nov 2006 Chamberlin KW. “Residencies and Internships in Geriatrics and Senior Care

Pharmacy.” ASCP’s 37th Annual Meeting, Phoenix, AZ. Nov 2005 Chamberlin KW. “Student Opportunities Panel Discussion.” ASCP’s 36th

Annual Meeting, Boston, MA. Mar 7, 2005 Chamberlin KW. “7+3 Chemotherapy Regimens.” University of Connecticut

Health Center, Department of Internal Medicine. Teaching Attending Rounds. Feb 11, 2005 Chamberlin KW. “Scratching Our Heads: What’s the Mechanism Behind β-

Blocker Induced Psoriasis?” University of Connecticut Health Center, Department of Internal Medicine. Teaching Attending Rounds.

Jan 2005 Chamberlin KW. “Did You Take Your Medications Today?” Western

Connecticut Area Agency on Aging: Oakville Senior Center, Oakville, CT. Oct 2004 Chamberlin KW, Schlesselman L. “So You’re Thinking of Doing a Residency

or Fellowship?” University of Connecticut School of Pharmacy P4 Career Day, Storrs, CT.

Oct 2004 Sill B, Chapron D, Chamberlin KW. Summerwood Series: "How to Get a

Good Night's Sleep." Summerwood Home, West Hartford, CT. Jun 2004 Chamberlin KW. “The Latest and ‘Greatest’ Drugs.” VA Connecticut

Healthcare System, Home-Based Primary Care & Geriatrics Medical Staff, West Haven, CT.

May 2004 Chamberlin KW. “Peer to Peer: The Why and How of a Geriatrics Pharmacy

Practice Residency.” ASCP’s 26th Midyear Conference, Scottsdale, AZ.

Page 25: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 25 of 31

May 2004 Chamberlin KW, Huie-Li A, Desilet A, Jeffery SM. “Identifying Risk Factors for Drug Related Problems in the Elderly Patients in the Home Setting.” Eastern States Conference, Baltimore, MD.

Feb 2004 Chamberlin KW. “Clinical Dilemmas in the Management of Dyspnea in End-

of-Life Care.” University of Connecticut School of Pharmacy, Storrs, CT.

Teaching Summary Annual PharmD Classes / Courses PHRX 4055: Advanced Clinical Concepts in Pain Management – Chronic Low

Back Pain; Geriatric Pain Management; Pharmacy Laws and Regulations in Pain Management. PHRX 3040: Neurology Module – ALS / MS; Pain (Acute and Opioid Prescribing Guidelines); Headaches/Migraines; Seizure Disorders; Course Coordinator (2012-current) PHRX 3011: CPPS I – Neurology seizure disorders case discussion PHRX 4042: Gastrointestinal Module – Nausea/Vomiting/Diarrhea/ Constipation Historical: PHRX 4043: Endocrine Module – Adrenal Disorders; Thyroid Disorders; Parathyroid Disorders; Osteoporosis PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion PHRX 4040: Psychiatry Module – Sleep Disorders PHRM 5007: Nonprescription Management – Constipation Management; Diarrhea Management PHRX 3011: CPPS I – Pain Management PHRX 3040: Autonomic Nervous Systems Module – Opioid Conversions; Management of Pain with Prescription NSAIDs and SMRs; Seizure Disorder Therapeutics PHRM 253-4004: Therapeutics I – Sleep Disorders; Dementias; Seizure Disorders PHRM 212-5009: Pharmacy Practice Lab – Wound and Minor Burn Care for the Pharmacist; Immunization Certification Practical Chamberlin KW, Jeffery SM. PHRM 254-4011 Therapeutics II Course Co-Coordinator (2006, 2007).

Page 26: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 26 of 31

Chamberlin KW, Wang F. PHRM 254-4011 Therapeutics II Course Co-Coordinator (2008, 2009). Chamberlin KW, Aneskievich BJ. PHRX 4043 Endocrine Course Co-Coordinator (2009, 2010).

Annual Medical Resident Program Classes / Courses Center on Aging – Medical Intern Case Conferences “Pharmacotherapy in the

Elderly.” [~6 times per year, 2011, 2012]. Annual Medical School Classes / Courses Chamberlin KW – team taught. “Public Health / Tuberculosis.” Vertically

Integrated Teams Aligned in Learning and Scholarship (VITALS). UConn School of Medicine. Chamberlin KW – team taught. “Pediatric Asthma.” Vertically Integrated Teams Aligned in Learning and Scholarship (VITALS). UConn School of Medicine. Chamberlin KW – team taught. “Pain.” Vertically Integrated Teams Aligned in Learning and Scholarship (VITALS). UConn School of Medicine. Chamberlin KW – team taught. “Obesity.” Vertically Integrated Teams Aligned in Learning and Scholarship (VITALS). UConn School of Medicine. Chamberlin KW – team taught. “Launch.” Vertically Integrated Teams Aligned in Learning and Scholarship (VITALS). UConn School of Medicine. Chamberlin KW. “Doctors and Drugs.” University of Connecticut School of Medicine. Four, 1-hour lectures (May 2013, 2014, 2015, 2016) Historical “Patient-Controlled Analgesia.” 3rd year Medical Students Neuroscience Homeweek [2-3 times per year]

Service – Professional (local, state, & national) 2017 – 2020 ASHP Section of Inpatient Care Practitioners SAG on Pharmacy Practice

Experiences Precepting, member 2018 – present UConn School of Pharmacy & Connecticut State Residency Programs

Preceptor Development Conference Planning Committee, member 2018 – present Project ECHO Expert Panel Hub on Pain Management, member 2017 – present CSHP Catch the Wave Greg Gousse Residency Conference Planning

Committee, member 2016 – 2017 American College of Clinical Pharmacy (ACCP) Educational Affairs

Committee, member

Page 27: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 27 of 31

2015 – present State of Connecticut Medical Assistance Program (Medicaid) Pharmaceutical and Therapeutics (P&T) Committee, Vice Chair

2014 – 2015 ASCP Chapters & Affiliates Committee (CAC), member 2013 – 2016 ASHP Section of Clinical Specialists and Scientists – Special Advisory Group

on Preceptor Skills Development, member May 2012 – Nov 2015

State of Connecticut Medical Assistance Program (Medicaid) Pharmaceutical and Therapeutics (P&T) Committee, member

2012 – 2013 ASCP National Nominations Committee (1-year appointment) 2011 – 2012 ASCP Professional Development Curriculum Committee [ASCP-PDCC]

(1-year appointment), member 2011 – 2015 CT-ASCP President-Elect (2011-2013) and Chapter President (2013-2015) 2011 – 2012 ASHP Section of Ambulatory Care Practitioners Educational Steering

Committee (1-year appointment), member 2006 ASCP Research and Education Foundation Leadership in Education Award

Selection Committee, member 2006 – present CPA Bioterrorism Clinical Advisory Team (C.A.T.) 2005 – 2006 ASCP National Education Advisory Committee (EAC), member 2005 – 2014 CPA Awards & Scholarship Committee, member 2005 – 2013 CT-ASCP Annual Senior Symposium Continuing Education Coordinator 2004 – 2008 Connecticut Advisory Committee to the Rhode Island Geriatric Education

Center (RIGEC), member 2004 – 2011 CT-ASCP Board of Directors (’04 – ’07 [3-year term]; ’07 – ’11 [4-year term

due to bylaws change]) 2004 – present CT-ASCP Communications Committee Member 2004 ASCP Research and Education Foundation Arnold S. Feldman Memorial

Senior Care Pharmacy Scholarship Selection Committee Member 2004 – 2005 CPA Bioterrorism Response Team Captain, Region 2 2003 – 2018 Senior Symposium Planning Committee Member (CT-ASCP) 2001 APhA-ASP National Executive Nominations Committee 2000 – 2001 Region I APhA-ASP Regional Delegate to the Executive Committee

Page 28: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 28 of 31

Service – School & University 2019 – present UConn Health Medical Grand Rounds Planning Committee, member 2017 – present UConn Health Opioid Task Force, member 2017 – 2018 UConn School of Pharmacy Department of Pharmacy Practice Promotion,

Tenure, Reappointment Advisory Committee (DPP PTRAC), Chair 2017 – present University of Connecticut School of Pharmacy Academic and Technical

Standards Committee, Chair 2016 – 2018 American Association of Colleges of Pharmacy (AACP) Faculty Delegate for

UConn School of Pharmacy [Alternate, 2016-17; Delegate, 2017-18] 2015 – Jun 2016 UConn Health Palliative Care Advisory Committee 2015 – 2017 UConn School of Pharmacy Department of Pharmacy Practice Promotion,

Tenure, Reappointment Advisory Committee (DPP PTRAC) 2015 – present University of Connecticut School of Pharmacy Interprofessional Education

Committee, Chair 2015 – present University of Connecticut Committee on Interprofessional Excellence in

Healthcare (cIPEH), member 2014 – 2019 University of Connecticut Academic Integrity Hearing Board, member 2014 UConn Health Department of Pharmacy Clinical Coordinator Search

Committee 2014 University of Connecticut School of Pharmacy, Department of Pharmacy

Practice – Didactic Education SWOT Committee, Co-Chair 2014 UConn Health Department of Pharmacy Administrative Assistant Search

Committee 2014 University of Connecticut School of Pharmacy Departmental Merit Review

Revision Committee 2013 – present University of Connecticut Health Center Department of Pharmacy Annual

Professional Day Planning Committee 2013 – present University of Connecticut School of Pharmacy Young Alumni Steering

Committee 2013 – 2016 University of Connecticut Health Center Palliative Care Interdisciplinary Team

Review Board 2012 – 2013 University of Connecticut School of Pharmacy Business Office Search

Committee

Page 29: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 29 of 31

2012 – 2013 University of Connecticut Health Center Medication Reconciliation Committee, member

2012 – present University of Connecticut Health Center Residency Advisory Committee

(RAC), Chair 2011 – 2016 University of Connecticut School of Pharmacy Academic and Technical

Standards Committee, member 2009 University of Connecticut Health Center Pain Team Assessment Committee

[chair = Nancy Baccaro, APRN] 2007 – 2008 University of Connecticut Health Center Pharmaceutical Industry Policy

Committee Member [chair = Jacqueline Nissen, MD] 2007 – 2008 University of Connecticut, Department of Pharmacy Practice Internal Medicine

Faculty Search Committee, Chair 2006 – 2009 University of Connecticut School of Pharmacy Senior Awards and Scholarships

Committee Member 2006 – 2007 University of Connecticut School of Pharmacy, Department of Pharmacy

Practice Workload Metrics Analysis Committee, Chair 2006 – 2009 University of Connecticut Health Center Collaborative Center for Clinical Care

Improvement – Pain and Palliative Care Subgroup, Co-Chair 2004 – 2006 University of Connecticut Health Center Collaborative Center for Clinical Care

Improvement Pain Subgroup Member 2004 – 2009 University of Connecticut School of Pharmacy Assessment Committee

Member 2000 – 2001 University of Connecticut School of Pharmacy, APhA-ASP Chapter President 2000 – 2001 University of Connecticut School of Pharmacy Scholarship Committee 1999 – 2001 University of Connecticut Committee on Undergraduate General Education

Requirements Revision 1999 – 2003 University of Connecticut School of Pharmacy Class President Service - Select Volunteer and Extracurricular Activities 2016 – present Assistant Coach, AAA Minors Little League

Baseball (spring and fall ball) Forestville Little League

Forestville, CT

2015 – 2016 Assistant Coach, Instructional League Baseball

Forestville Little League Forestville, CT

Page 30: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 30 of 31

2014 Assistant Coach, U-8 Bristol Soccer Club

Bristol, CT

2014 Manager/Head Coach, T-Ball

Forestville Little League Forestville, CT

2013 Assistant Coach, T-Ball

Forestville Little League Forestville, CT

2012 Coordinator, DinoMites Soccer (U-4)

Bristol Soccer Club Bristol, CT

2011 – 2014 Board of Directors

Bristol Soccer Club Bristol, CT

2011 Head Coach, Micro Team Soccer (U-6)

Bristol Soccer Club Bristol, CT

2003 – 2009 Bugles Across America CT 1997 – 2000 University of Connecticut Crew Team Storrs, CT 1992 – 2015 Multiple Sclerosis Society’s MS Walk ME & CT Awards & Recognition 2019 Louis P. Jeffery Award for distinguished service to the profession and

commitment to residency training 2018 University of Connecticut School of Pharmacy Dean Robert L. McCarthy

Faculty Service Award 2017 University of Connecticut School of Pharmacy, Class of 2017 “Dennis J.

Chapron Faculty Preceptor of the Year” Award 2016 Appointed Fellow, American Society of Consultant Pharmacists (FASCP) 2009 CT-ASCP Consultant Pharmacist of the Year 2007 University of Connecticut School of Pharmacy, Class of 2007 “Roche

Preceptor of the Year” Award 2007 Categorical Internal Medicine Program Excellence in Teaching Award

[David S. Frederick, MD Award] [UConn Health Center Internal Medicine Medical Residency Program]

2006 University of Connecticut Health Center UConnPride Council P.A.W.S. Award 2003 APhA Mortar and Pestle Professionalism Award

Page 31: Kevin W. Chamberlin, PharmD, FASCP · 2020-01-21 · PHRX 5045: Special Populations – Geriatric Syndromes; Falls; Osteoarthritis; Geriatric case discussion . PHRX 4040: Psychiatry

Last updated: 1/17/2020 Page 31 of 31

Professional Affiliations 2014 – present American Association of Colleges of Pharmacy (AACP) 2014 – present American College of Clinical Pharmacy (ACCP) 2013 – present Connecticut Society of Health-System Pharmacists (CSHP) 2011 – 2012 American Geriatrics Society (AGS) 2003 – present American Society of Health System Pharmacists (ASHP) 2003 – present American Society of Consultant Pharmacists (ASCP) 2003 – present Connecticut Society of Consultant Pharmacists (CT – ASCP) 2001 – present Phi Lambda Sigma – Alpha Gamma Chapter – Pharmacy Leadership Society 1999 – present Connecticut Pharmacists Association (CPA) 1999 – 2008 American Pharmacists Association (APhA)